|
VDAC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.176070E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.10209999999389E-05 |
| Normal-vs-Stage2 |
3.242800E-01 |
| Normal-vs-Stage3 |
1.90475999999329E-05 |
| Normal-vs-Stage4 |
2.578700E-04 |
| Stage1-vs-Stage2 |
1.259000E-01 |
| Stage1-vs-Stage3 |
6.079000E-01 |
| Stage1-vs-Stage4 |
6.729600E-01 |
| Stage2-vs-Stage3 |
8.555500E-02 |
| Stage2-vs-Stage4 |
1.044440E-01 |
| Stage3-vs-Stage4 |
9.681000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.14039999957683E-07 |
| Normal-vs-AfricanAmerican |
7.597600E-01 |
| Normal-vs-Asian |
8.36649999946815E-07 |
| Caucasian-vs-AfricanAmerican |
2.078900E-03 |
| Caucasian-vs-Asian |
2.882400E-01 |
| AfricanAmerican-vs-Asian |
5.562800E-04 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.960700E-04 |
| Normal-vs-Female |
1.818160E-04 |
| Male-vs-Female |
6.450400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.400900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.34360000003664E-06 |
| Normal-vs-Age(61-80Yrs) |
9.904300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.262380E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.086380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.213500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.264200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.077600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.775600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.847750E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.729400E-01 |
| Classical-VS-Follicular |
1.770400E-02 |
| Classical-VS-Other |
4.741400E-01 |
| Classical-VS-Normal |
8.80430000016474E-07 |
| Tall-VS-Follicular |
2.891600E-02 |
| Tall-VS-Other |
3.735000E-01 |
| Tall-VS-Normal |
1.760860E-04 |
| Follicular-VS-Other |
7.865200E-01 |
| Follicular-VS-Normal |
1.405970E-01 |
| Other-VS-Normal |
2.241200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.98939999999893E-05 |
| Normal-vs-N1 |
5.00260000091401E-08 |
| N0-vs-N1 |
1.244490E-02 |
|
|
